Silencing Leukocyte Immunoglobulin-Like Receptor A1 in Monocytes Inhibits Inflammation in Mice with Multiple Sclerosis

Conclusion: The key findings of this study collectively propose that LILRA1 suppression exerts a potent anti-inflammatory effect on MS mice. Overall, LILRA1 downregulation presents a promising therapeutic strategy for the treatment of MS.Neuroimmunomodulation
Source: Neuroimmunomodulation - Category: Allergy & Immunology Source Type: research